NMN combined with citicoline — a precursor to healthy brain fat — counteracts cognitive impairment, inflammation, and brain damage in a rat model for dementia.
Highlights:
Vascular dementia (VD) is considered the second most common type of dementia after Alzheimer’s, especially in North America and Europe. The risk of VD increases with age, so safeguards to limit this risk are crucial. Now, researchers from Hangzhou Normal University in China may have found such a safeguard.
As reported in Cellular and Molecular Neurobiology, Zhao and colleagues show that NMN and citicoline work synergistically to mitigate memory loss in VD rats. They also show that NMN and citicoline reduce inflammation and brain damage, revealing how the combination of these anti-aging compounds may provide greater cognitive protection than if they were taken separately. The authors conclude,
“We have proved that the combination of citicoline and NMN in [VD] rats would maintain the normal physical condition of neurons, inhibit neuroinflammation in the brain, and ultimately attenuate the white matter damage and cognitive dysfunction of [VD] rats.”
To model VD, Zhao and colleagues surgically hindered blood flow to the brains of rats. Without sufficient blood, brain tissue begins to deteriorate, and the hippocampus is particularly vulnerable. Hence, these VD rats showed deficits in key aspects of cognition — learning and memory.
To determine the effects of NMN and citicoline, the researchers first administered each anti-aging compound separately to the VD rats. Using the novel object recognition test — a method for studying memory in rodents — the researchers found that neither NMN nor citicoline alone significantly improved the learning and memory of the rats. However, administering NMN and citicoline together led to synergetic improvements in memory.
The primary physiological defect underlying VD is inflammation, so Zhoa and colleagues assessed this hallmark of aging via measuring microglia cells. When activated, microglia promote inflammation that could cause brain damage. The results showed that NMN combined with citicoline reduced microglia activation by nearly 3-fold, suggesting a reduction in brain inflammation.
When more microglia are activated in the brain we see more brain inflammation which causes damage to myelin — a layer of fat that insulates and protects our neurons. Since myelin appears as white matter at the macroscopic level, damage to myelin can disrupt white matter integrity. Zhao and colleagues found that VD rats had reduced white matter integrity. However, NMN combined with citicoline protected against this brain damage.
Overall, the findings of Zhao and colleagues suggest that NMN and citicoline combined synergistically protect against VD by reducing inflammation-induced brain damage. Furthermore, since inflammation-induced brain degeneration is a common feature of brain aging, this anti-aging combination could slow or prevent the general brain deterioration that occurs with aging.
In the brain, citicoline maintains a brain fat (lipid) called phosphatidylcholine (PC) and improves the survival of neurons. PC and other brain fats are known to contribute to the prevention of cognitive decline in humans. Furthermore, NMN has previously been shown to improve the cognition of aged rats and rats with vascular dementia. Together, these studies give credence to citicoline and NMN improving the cognition of humans, but this has not yet been tested.
Model: Male Sprague-Dawley rats with occluded carotid arteries to induce vascular dementia
Dosage: Intraperitoneal injection of 160 mg/kg of citicoline and 40 mg/kg NMN